Draxxin 25 Injectable Solution is a drug owned by ZOETIS INC. It is protected by 7 US drug patents filed from 2018 to 2021. All patents have expired. Details of Draxxin 25 Injectable Solution’s patents and their expiration are given below.
Exclusivity Information
Draxxin 25 Injectable Solution holds 1 exclusivity out of which 1 has expired. Details of Draxxin 25 Injectable Solution's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Jul 09, 2016 |
About Draxxin 25 Injectable Solution
Draxxin 25 Injectable Solution is a drug
owned by ZOETIS INC.
Draxxin 25 Injectable Solution uses
Tulathromycin as the active
ingredient.
Active Ingredient:
Draxxin 25 Injectable Solution uses
Tulathromycin as the active ingredient.
Check out other Drugs and Companies using
Tulathromycin ingredient.